The Influence of NPPA/NPPB Haplotype on Natriuretic Peptide Plasma Levels
NCT04327258 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 437
Last updated 2020-03-31
Summary
Crosssectional study to analyse the genetic influence on levels of cardiac biomarkers (BNP, NT-proBNP).
Conditions
- Anesthesia
- Surgical Procedure, Operative
Sponsors & Collaborators
-
Insel Gruppe AG, University Hospital Bern
lead OTHER
Principal Investigators
-
Frank Stüber, Prof. MD · Department of Anaesthesiology and Pain Medicine, Inselspital, University of Bern
-
Ulrike M Stamer, MD · Department of Anaesthesiology and Pain Medicine, Inselspital, University of Bern
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-01-31
- Primary Completion
- 2014-12-31
- Completion
- 2014-12-31
Countries
- Switzerland
Study Locations
More Related Trials
-
Vascular Responses to Sympathetic Activation and Altered Shear Rate: The Impact of Hypertension and Sodium Intake
NCT03558022 ·Status: COMPLETED ·Phase: NA
-
A Study for the Identification of Biomarker Signatures for Early Detection of Pulmonary Hypertension (PH)
NCT04193046 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Evaluation of the Role of Brain Natriuretic Peptide in Acute Coronary Syndrome .
NCT06734416 ·Status: NOT_YET_RECRUITING
-
A Prospective Study to Assess the Screening Value of N-terminal Pro-B-type Natriuretic Peptide (NT-proBNP) for the Identification of Patients That Benefit From Additional Cardiac Testing Prior to Vascular Surgery
NCT00519961 ·Status: UNKNOWN ·Phase: NA
-
Prognostic Value of Plasma Biomarkers Among Patients With Hypertension
NCT04107584 ·Status: UNKNOWN
-
New Biomarkers and Difficult-to-treat Hypertension
NCT03034265 ·Status: COMPLETED
-
Mechanisms Underlying Abnormal Ambulatory BP Patterns
NCT00005346 ·Status: COMPLETED
-
Screening for Primary Aldosteronism in a Population of Patients With Hypertension
NCT03105531 ·Status: COMPLETED
-
Natriuretic Peptide System as Therapy in Human Preclinical Left Ventricle Dysfunction
NCT00387621 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Pathophysiological Mechanisms of Hypertensive LVH:Optimising Regression
NCT00518479 ·Status: COMPLETED ·Phase: NA
-
Genetic of Response to Acute Saline Load Test in Hypertension (Naload)
NCT04625569 ·Status: RECRUITING
-
Target Organ Damage and Polymorphisms Vav-2 and Vav-3 in Hypertensive Subjects
NCT02022618 ·Status: COMPLETED
-
Genetic Predisposition to High Blood Pressure
NCT07181213 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Analyzing Genetic Factors Involved in Blood Pressure Changes Due to Salt and Potassium Intake (The GenSalt Study)
NCT00721721 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of High and Low Sodium Intake on Urinary Aquaporin-2 in Healthy Humans.
NCT00345215 ·Status: COMPLETED ·Phase: NA
-
Metabolic Effects of Natriuretic Peptide Hormones
NCT03397966 ·Status: TERMINATED ·Phase: PHASE4
-
Use of Impedance Cardiography and Applanation Tonometry for Prediction of the Antihypertensive Effect of Two Drugs
NCT03560804 ·Status: COMPLETED ·Phase: NA
-
Emerging Biomarkers in Hypertension
NCT02064218 ·Status: UNKNOWN
-
Urinary Kallikrein and Hypertension: A Prospective Study
NCT00005261 ·Status: COMPLETED
-
The Effect of High and Low Sodium Intake on Urinary Aquaporin-2 in Essential Hypertension
NCT00345124 ·Status: COMPLETED ·Phase: NA
-
The Effect of Sodium Nitrite on Renal Function and Blood Pressure in Hypertensive Versus Healthy Subjects
NCT02527837 ·Status: UNKNOWN ·Phase: PHASE1
-
Changes in Measured Plasma Volume, Glycocalyx and Atrial Natriuretic Peptide During Anaesthesia
NCT02832596 ·Status: COMPLETED ·Phase: NA
-
Urinary Prostaglandin as a Potential Predictive Marker for Thiazide-induced Hyponatremia
NCT05542056 ·Status: RECRUITING
-
Relationship Between Genes Important in Blood Pressure Regulation and Blood Pressure Therapy in Hypertension
NCT02524873 ·Status: COMPLETED
-
Blood Pressure Lowering Effect of Transcutaneous Electrical Nerve Stimulation
NCT01390701 ·Status: COMPLETED ·Phase: NA